Mitochondrial DNA copy number in human disease: the more the better?

R Filograna, M Mennuni, D Alsina, NG Larsson - FEBS letters, 2021 - Wiley Online Library
Most of the genetic information has been lost or transferred to the nucleus during the
evolution of mitochondria. Nevertheless, mitochondria have retained their own genome that …

Oxidative stress in neurodegenerative diseases: from a mitochondrial point of view

G Cenini, A Lloret, R Cascella - Oxidative medicine and …, 2019 - Wiley Online Library
Age is the main risk factor for a number of human diseases, including neurodegenerative
disorders such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral …

[HTML][HTML] Type-I-interferon signaling drives microglial dysfunction and senescence in human iPSC models of Down syndrome and Alzheimer's disease

M Jin, R Xu, L Wang, MM Alam, Z Ma, S Zhu… - Cell Stem Cell, 2022 - cell.com
Microglia are critical in brain development and Alzheimer's disease (AD) etiology. Down
syndrome (DS) is the most common genetic developmental disorder and risk factor for AD …

Mitochondrial abnormalities in Parkinson's disease and Alzheimer's disease: can mitochondria be targeted therapeutically?

R Macdonald, K Barnes, C Hastings… - Biochemical Society …, 2018 - portlandpress.com
Mitochondrial abnormalities have been identified as a central mechanism in multiple
neurodegenerative diseases and, therefore, the mitochondria have been explored as a …

A key role for MAM in mediating mitochondrial dysfunction in Alzheimer disease

E Area-Gomez, A de Groof, E Bonilla… - Cell death & …, 2018 - nature.com
In the last few years, increased emphasis has been devoted to understanding the
contribution of mitochondria-associated endoplasmic reticulum (ER) membranes (MAM) to …

Fisetin, potential flavonoid with multifarious targets for treating neurological disorders: An updated review

AR Ravula, SB Teegala, S Kalakotla… - European journal of …, 2021 - Elsevier
Neurodegenerative disorders pose a significant health burden and imprint a debilitative
impact on the quality of life. Importantly, aging is intricately intertwined with the progression …

Mitochondrial dysfunction in Alzheimer's disease: a biomarker of the future?

SM Bell, K Barnes, M De Marco, PJ Shaw, L Ferraiuolo… - Biomedicines, 2021 - mdpi.com
Alzheimer's disease (AD) is the most common cause of dementia worldwide and is
characterised pathologically by the accumulation of amyloid beta and tau protein …

The role of mitochondrial dysfunction in Alzheimer's disease: a potential pathway to treatment

AB Reiss, S Ahmed, C Dayaramani, AD Glass… - Experimental …, 2022 - Elsevier
Background Alzheimer's disease (AD) is the most prevalent form of dementia worldwide and
is characterized by progressive memory loss and cognitive impairment. Our understanding …

Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas

E Area-Gomez, C Guardia-Laguarta… - The Journal of …, 2019 - Am Soc Clin Investig
Mitochondrial respiratory deficiencies have been observed in numerous neurodegenerative
disorders, such as Alzheimer's and Parkinson's diseases. For decades, these reductions in …

Disentangling mitochondria in Alzheimer's disease

A Johri - International journal of molecular sciences, 2021 - mdpi.com
Alzheimer's disease (AD) is a major cause of dementia in older adults and is fast becoming
a major societal and economic burden due to an increase in life expectancy. Age seems to …